Cancer Commons Presents New Pancreatic Cancer Research Findings at AACR Conference

Today, our Director of Scientific and Clinical Affairs, Lola Rahib, PhD, presented initial findings from our real-world data registry on a novel treatment combination for pancreatic cancer patients. Performed in collaboration with xCures and the University of Utah’s Huntsman Cancer Institute, this research was presented at the Special Conference on Advancing Precision Advancing Precision Medicine Drug Development: Incorporation of Real-World Data and Other Novel Strategies, hosted by the American Association for Cancer Research (AACR) in San Diego, CA.

According to Dr. Rahib, the new findings “demonstrate the feasibility of utilizing a real-world data registry to rapidly report on the safety profile and clinical benefits of novel cancer drug combinations in patients who are receiving therapies outside of a standard clinical trial. Using this approach created speed and cost efficiencies relative to standard multi-center oncology clinical trials.”

Learn more about the findings in our feature article written by Dr. Rahib.